Sacral Nerve Stimulation Market By Product (Devices, Accessories), By Application (Urinary and Fecal Incontinence, Chronic Anal Fissure, Others), By End User (Hospitals, Specialty Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2023-2

Sacral Nerve Stimulation Market By Product (Devices, Accessories), By Application (Urinary and Fecal Incontinence, Chronic Anal Fissure, Others), By End User (Hospitals, Specialty Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

The sacral nerve stimulation market was valued at $422.66 million in 2022 and is estimated to reach $702.10 million by 2032, exhibiting a CAGR of 5.2% from 2023 to 2032. Sacral nerve stimulation is a clinical procedure used to treat certain situations associated with bladder and bowel dysfunction, consisting of urinary and fecal incontinence. It involves implantation of a small device, called a neurostimulator, which supplies electrical impulses to the sacral nerves located near the lower back. These sacral nerves are accountable for controlling the muscle tissues involved in bladder and bowel function.

During the sacral nerve stimulation procedure, the neurostimulator is typically implanted under the skin, often in the buttock area. Thin, insulated wires with electrodes at their tips, called leads, are then placed near the sacral nerves. Once the neurostimulator is activated, it delivers mild electrical signals to the sacral nerves, which modulate their activity. The electrical impulses sent by the neurostimulator help to regulate nerve signals, improve communication between the nerves and the bladder or bowel, and restore proper control over these functions. By stimulating the sacral nerves, sacral nerve stimulation aims to improve muscle coordination, reduce episodes of incontinence, and potentially alleviate symptoms of overactive bladder or fecal urgency. The major factors driving the growth of the sacral nerve stimulation market include increase in the number of populaces suffering from urological incontinence conditions, technological advancements in sacral nerve stimulation devices, and rise in adoption of sacral nerve stimulation devices.

The rising overactive bladder or fecal urgency conditions can be debilitating, affecting an individual’s quality of life and thus, requiring long-term effective treatment. Sacral nerve stimulation devices have emerged as an effective treatment option for patients who have not responded to other traditional forms of therapy.

Furthermore, sacral nerve stimulation devices have undergone significant technological advancements, leading to smaller, flexible, and more effective devices. For example, newer devices are now compatible with MRI scans, eliminating the need for device removal during imaging procedures. Furthermore, introduction of rechargeable batteries and wireless capabilities enhances patient comfort and convenience. These technological advancements are anticipated to boost the demand for sacral nerve stimulation devices, as patients and physicians seek more efficient and user-friendly options.

However, the high cost of sacral nerve stimulators and potential risks and complications associated with the procedure act as restraints to the market growth. The high upfront costs limit accessibility, particularly in regions with limited healthcare resources, while concerns about risks and complications are expected to deter potential patients and healthcare providers from adopting this therapy.

Moreover, the global population is aging rapidly, and this demographic shift is expected to drive the demand for sacral nerve stimulation devices. As per the U.S. Census Bureau 2022, more than 56 million adults aged 65 and above live in the U.S., accounting for almost 16.9% of the nation’s population; thus, rise in geriatric population is anticipated to fuel the growth of the market. Furthermore, rise in demand of implantable stimulators owing to its advantages drives the market growth. Thus, the above factors are anticipated to fuel the market growth.

The sacral nerve stimulation market is segmented into product, application, end user, and region. On the basis of product, the market is bifurcated into devices and accessories. On the basis of application, it is categorized into urinary fecal incontinence, chronic anal fissure, and others (overactive bladder syndrome, urinary frequency). On the basis of end user, it is segregated into hospitals, specialty clinics, and others (research centers, ambulatory surgical centers). Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major key players that operate in the global sacral nerve stimulation market are Medtronic Plc, Beijing PINS Medical Co., Ltd., Saluda Medical Pty Ltd., and Axonics, Inc. The key players have adopted strategies such as acquisition, product launch, and product approval to expand their product portfolio.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the sacral nerve stimulation market analysis from 2022 to 2032 to identify the prevailing sacral nerve stimulation market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the sacral nerve stimulation market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global sacral nerve stimulation market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

Devices
Accessories

By Application

Urinary and Fecal Incontinence
Chronic Anal Fissure
Others

By End User

Hospitals
Specialty Clinics
Others

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Axonics, Inc.
Beijing PINS Medical Co., Ltd.
Saluda Medical Pty Ltd.
Medtronic plc

Please Note: It will take 7-10 business days to complete the report upon order confirmation.